glp-1 or semaglutide Comparing Ozempic, Wegovy and Other Drugs GLP-1 Genetics: How Genes Affect
Description
Most clinical guidelines now frame GLP-1 agonist treatment as indefinite rather than time-limited, similar to treating hypertension or diabetes
See Caffeine and AFib for more details
The changes from baseline with orforglipron were significant, but they were not significantly different from placebo (Fig
The addition of glucagon receptor agonism introduces some theoretical safety considerations not seen with GLP-1 agonists alone
The distinction matters because each substance influences weight loss and glucose control through separate physiological routes
It requires careful monitoring and a clear therapeutic strategy developed by your healthcare provider
